CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Open-market buy Director bought 500 shares at $3.31 ($1,655)
- 4 Open-market buy Director bought 2,000 shares at $2.29 ($4,580)
- 4 Open-market buy Director bought 2,000 shares at an average $2.46 ($4,920)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- 4 Open-market sale Vice President-Finance & CFO sold 500 shares at $3.76 ($1,880)
- 4 Open-market sale Vice President-Finance & CFO sold 3,500 shares at an average $3.78 ($13,234)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Open-market buy Director bought 5,616 shares at $4.59 ($25,777)
- 4 Open-market buy Director bought 1,000 shares at $4.70 ($4,700)
- 4 Open-market buy Director bought 1,400 shares at $4.49 ($6,286)
Page 22 of 50 · 983 filings